title: Omalizumab (an anti-IgE antibody) in the treatment of severe atopic eczema.
authors: Allergy and Clinical Immunology Service, Regional Hospital "Licenciado Adolfo López Mateos", ISSSTE, Mexico City, Mexico. mariaelena_uli@hotmail.com
authors: M E
authors: ME
authors: Ramírez del Pozo
authors: E
authors: E
authors: Contreras Contreras
authors: J
authors: J
authors: López Tiro
authors: J
authors: J
authors: Gómez Vera
mesh_terms: D000293:Adolescent; D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage* / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D011788:Quality of Life; D012720:Severity of Illness Index
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E